Showing 21 - 40 results of 253 for search '"GUO YABING"', query time: 1.59s Refine Results  

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran
Published in The Lancet (British edition) (30.09.2023)

Get full text
Journal Article

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

by Qin, Shukui, Chen, Minshan, Kudo, Masatoshi, Yopp, Adam C, Wang, Lu, Tak, Won Young, Lian, Qinshu, Spahn, Jessica H, Wang, Yulei, Chow, Pierce K H, Poursoltan, Pirooz, Kiberu, Andrew, Chittajallu, Renuka, Sood, Siddarth, Stauber, Rudolf, Peck-Radosavljevic, Markus, Decaestecker, Jochen, Verset, Gontran, Cunha Júnior, Ademar, Faria, Luiza, Asselah, Jamil, Brahmania, Mayur, Li, Qiang, Chen, Zhendong, Zhao, Haitao, Liu, Hongming, Wu, Feixiang, Zheng, Qichang, Li, Haitao, Wen, Tianfu, Qin, Shukui, Liu, Yunpeng, Chen, Minshan, Bai, Yuxian, Zhao, Hong, Yin, Tao, Ding, Youming, Jia, Weidong, Xia, Yongxiang, Xia, Qiang, Guzmán, Adrián, Corrales, Luis, Kubala, Eugen, Blanc, Jean Frederic, Borg, Christophe, Decaens, Thomas, Uguen, Thomas, Heurgue, Alexandra, Trojan, Joerg, Gonzalez-Carmona, Maria Angeles, Schotten, Clemens, Kandulski, Arne, Yau, Thomas, Scartozzi, Mario, Leonardi, Francesco, Ghidini, Michele, Kudo, Masatoshi, Koga, Hironori, Kawamura, Yusuke, Hasegawa, Kiyoshi, Marusawa, Hiroyuki, Hayashi, Hiromitsu, Lee, Han Chu, Paik, Seung Woon, Kim, Do Young, Jeong, Sook-Hyang, Kim, Hyeyeong, Yoon, Seung Kew, Yoon, Jung-Hwan, Villalobos, Ricardo, Martinez Rodriguez, Jorge Luis, Oyervides Juarez, Victor, Hernández, Carlos Alberto, de Vos-Geelen, Judith, Gane, Edward, Torres Mattos, Cesar, Alyasova, Anna, Sekacheva, Marina, Ledin, Evgeny, Toh, Han Chong, Lopez Lopez, Carlos, Muñoz Martin, Andres Jesus, Reig Monzón, Maria, Delgado Mingorance, Ignacio, Minguez Rosique, Beatriz, Huang, Yi-Hsiang, Huang, Jee-Fu, Su, Wei-Wen, Maneenil, Kunlatida, Harputluoglu, Hakan, Buchschacher, Gary, Xiong, Henry, Patel, Mital, Li, Daneng, Brooks, Gabriel, Patel, Reema, Kardosh, Adel, Shah, Ashesh, Burris III, Howard, Hsiehchen, David
Published in The Lancet (British edition) (18.11.2023)

Get full text
Journal Article

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

by Llovet, Josep M, Kudo, Masatoshi, Meyer, Tim, Qin, Shukui, Ikeda, Masafumi, Ren, Zhenggang, Lim, Ho Yeong, Cheng, Ann-Lii, Galle, Peter R, Wang, Anran, Mody, Kalgi, Dutcus, Corina, Siegel, Abby B, Thompson, Alexander, Andelkovic, Vladimir, Knox, Jennifer, Davies, Janine, Asselah, Jamil, Brahmania, Mayur, Xu, Ruocai, Pan, Hongming, Gu, Kangsheng, Hao, Chunyi, Cao, Peiguo, Xiao, Juxiang, Bai, Yuxian, Chen, Xiaoming, Yan, Dong, Zhao, Hong, Bonilla, Carlos, Zambrano, Angela, Lema, Mauricio, Restrepo Gutierrez, Juan Carlos, Ramos, Victor, LeSourd, Samuel, Edeline, Julien, Bourliere, Marc, Regnault, Helene, Dauvois, Barbara, Schulze, Kornelius, Waidmann, Oliver, Berres, Marie-Luise, Berg, Thomas, Waldschmidt, Dirk T, Bitzer, Michael, Duffy, Austin, Tonini, Giuseppe, Rizzo, Mimma, Biscaldi, Elisa, Ikeda, Masafumi, Kudo, Masatoshi, Numata, Kazushi, Marusawa, Hiroyuki, Kato, Naoya, Morimoto, Manabu, Yamashita, Tatsuya, Koga, Hironori, Masaki, Tsutomu, Tateishi, Ryosuke, Inaba, Yoshitaka, Arakawa, Tomohiro, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Tae-You, Hernandez Hernandez, Carlos, Motola Kuba, Daniel, Segura Gonzalez, Manuel, Cabrera Luviano, Jesus, Ramirez Godinez, Francisco, Stedman, Catherine, Wyrwicz, Lucjan, Kraj, Leszek, Surma-Wlodarczyk, Renata, Breder, Valeriy, Sekacheva, Marina, Orlova, Rashida, Vasilyev, Alexander, Zukov, Ruslan, Minguez, Beatriz, Matilla Pena, Ana, Fernandez Castroagudin, Javier, Garcia Sanchez, Araceli, Jeng, Long-Bin, Dechaphunkul, Arunee, Seker, Mesut, Bilici, Mehmet, Cil, Timucin, Ulahannan, Susanna, Zakari, Ahmed, Feun, Lynn, Al-Rajabi, Raed, Sung, Max, Kardosh, Adel, Dodlapati, Jyothi, Agrawal, Saurabh, Gopaluni, Srivalli, Loaiza-Bonilla, Arturo, Frenette, Catherine
Published in The lancet oncology (01.12.2023)

Get full text
Journal Article